Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study

Atherosclerosis

Volumn 238, Issue 2, 2015, Pages 409-414

  Kadoya, Manabu ^a   Koyama, Hidenori ^a   Kurajoh, Masafumi ^a   Kanzaki, Akinori ^a   Kakutani Hatayama, Miki ^a   Okazaki, Hirokazu ^a   Shoji, Takuhito ^a   Moriwaki, Yuji ^a   Yamamoto, Tetsuya ^a   Emoto, Masanori ^b   Inaba, Masaaki ^b   Namba, Mitsuyoshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Actigraph; Carotid plaque; Cohort study; Heart rate variability; Sleep efficiency

Indexed keywords

ACTIMETRY; ADULT; AGED; ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; AUTONOMIC NERVOUS SYSTEM; CAROTID ARTERY; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEART; HEART RATE; HUMAN; INNERVATION; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP; STATISTICAL MODEL;

ACTIGRAPHY; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEART; HEART RATE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP;

EID: 84920885070     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.12.032     Document Type: Article

References (38)

1. Gullette E.C., Blumenthal J.A., Babyak M., Jiang W., Waugh R.A., Frid D.J., O'Connor C.M., Morris J.J., Krantz D.S. Effects of mental stress on myocardial ischemia during daily life. J.Am. Med. Assoc. 1997, 277:1521-1526.
2. Jain D., Shaker S.M., Burg M., Wackers F.J., Soufer R., Zaret B.L. Effects of mental stress on left ventricular and peripheral vascular performance in patients with coronary artery disease. J.Am. Coll. Cardiol. 1998, 31:1314-1322.
3. Krantz D.S., Sheps D.S., Carney R.M., Natelson B.H. Effects of mental stress in patients with coronary artery disease: evidence and clinical implications. J.Am. Med. Assoc. 2000, 283:1800-1802.
4. Koyama H., Fukuda S., Shoji T., Inaba M., Tsujimoto Y., Tabata T., Okuno S., Yamakawa T., Okada S., Okamura M., Kuratsune H., Fujii H., Hirayama Y., Watanabe Y., Nishizawa Y. Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis. Clin. J. Am. Soc. Nephrol. 2010, 5:659-666.
5. Kripke D.F., Garfinkel L., Wingard D.L., Klauber M.R., Marler M.R. Mortality associated with sleep duration and insomnia. Arch. Gen. Psychiatry 2002, 59:131-136.
6. Tamakoshi A., Ohno Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 2004, 27:51-54.
7. Gallicchio L., Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J.Sleep. Res. 2009, 18:148-158.
8. Cappuccio F.P., D'Elia L., Strazzullo P., Miller M.A. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33:585-592.
9. Patel S.R. Invited Commentary: understanding the role of sleep. Am. J. Epidemiol. 2009, 170:814-816. discussion 817-818.
10. Liao D., Cai J., Rosamond W.D., Barnes R.W., Hutchinson R.G., Whitsel E.A., Rautaharju P., Heiss G. Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC study. Atherosclerosis risk in communities study. Am. J. Epidemiol. 1997, 145:696-706.
11. Tsuji H., Larson M.G., Venditti F.J., Manders E.S., Evans J.C., Feldman C.L., Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996, 94:2850-2855.
12. Chambless L.E., Heiss G., Folsom A.R., Rosamond W., Szklo M., Sharrett A.R., Clegg L.X. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) Study, 1987-1993. Am. J. Epidemiol. 1997, 146:483-494.
13. Lorenz M.W., Polak J.F., Kavousi M., Mathiesen E.B., Volzke H., Tuomainen T.P., Sander D., Plichart M., Catapano A.L., Robertson C.M., Kiechl S., Rundek T., Desvarieux M., Lind L., Schmid C., DasMahapatra P., Gao L., Ziegelbauer K., Bots M.L., Thompson S.G. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379:2053-2062.
14. Polak J.F., Pencina M.J., Pencina K.M., O'Donnell C.J., Wolf P.A., D'Agostino R.B. Carotid-wall intima-media thickness and cardiovascular events. N.Engl. J. Med. 2011, 365:213-221.
15. Gottsater A., Ahlgren A.R., Taimour S., Sundkvist G. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin. Auton. Res. 2006, 16:228-234.
16. Melillo P., Izzo R., De Luca N., Pecchia L. Heart rate variability and target organ damage in hypertensive patients. BMC Cardiovasc. Disord. 2012, 12:105.
17. Pizzi C., Manzoli L., Mancini S., Bedetti G., Fontana F., Costa G.M. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010, 212:292-298.
18. Teramoto T., Sasaki J., Ishibashi S., Birou S., Daida H., Dohi S., Egusa G., Hiro T., Hirobe K., Iida M., Kihara S., Kinoshita M., Maruyama C., Ohta T., Okamura T., Yamashita S., Yokode M., Yokote K. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J.Atheroscler. Thromb. 2013, 20:517-523.
19. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl.1):S5-S10.
20. Kadoya M., Koyama H., Kanzaki A., Kurajoh M., Hatayama M., Shiraishi J., Okazaki H., Shoji T., Moriwaki Y., Yamamoto T., Inaba M., Namba M. Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors. Plos ONE 2014, 9:e105977.
21. Marino M., Li Y., Rueschman M.N., Winkelman J.W., Ellenbogen J.M., Solet J.M., Dulin H., Berkman L.F., Buxton O.M. Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography. Sleep 2013, 36:1747-1755.
22. Koyama H., Maeno T., Fukumoto S., Shoji T., Yamane T., Yokoyama H., Emoto M., Tahara H., Inaba M., Hino M., Shioi A., Miki T., Nishizawa Y. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003, 108:524-529.
23. Maeno T., Koyama H., Tahara H., Komatsu M., Emoto M., Shoji T., Inaba M., Miki T., Okuno Y., Nishizawa Y. The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes. Diabetes 2002, 51:1523-1528.
24. Handa N., Matsumoto M., Maeda H., Hougaku H., Ogawa S., Fukunaga R., Yoneda S., Kimura K., Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990, 21:1567-1572.
25. Yanase T., Nasu S., Mukuta Y., Shimizu Y., Nishihara T., Okabe T., Nomura M., Inoguchi T., Nawata H. Evaluation of a new carotid intima-media thickness measurement by B-mode ultrasonography using an innovative measurement software, intimascope. Am. J. Hypertens. 2006, 19:1206-1212.
26. Abe T., Aoki T., Yata S., Okada M. Sleep duration is significantly associated with carotid artery atherosclerosis incidence in a Japanese population. Atherosclerosis 2011, 217:509-513.
27. Silvestrini M., Rizzato B., Placidi F., Baruffaldi R., Bianconi A., Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002, 33:1782-1785.
28. Suzuki T., Nakano H., Maekawa J., Okamoto Y., Ohnishi Y., Yamauchi M., Kimura H. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004, 27:129-133.
29. Liao D., Cai J., Brancati F.L., Folsom A., Barnes R.W., Tyroler H.A., Heiss G. Association of vagal tone with serum insulin, glucose, and diabetes mellitus-The ARIC Study. Diabetes Res. Clin. Pract. 1995, 30:211-221.
30. Poliakova N., Despres J.P., Bergeron J., Almeras N., Tremblay A., Poirier P. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men. Metabolism 2012, 61:1270-1279.
31. Umetani K., Singer D.H., McCraty R., Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J.Am. Coll. Cardiol. 1998, 31:593-601.
32. Fujii H., Koyama H., Fukuda S., Tokai H., Tajima S., Koizumi J., Yamaguti K., Kuratsune H., Watanabe Y., Hirayama Y., Shoji T., Inaba M., Nishizawa Y. Autonomic function is associated with health-related quality of life in patients with end-stage renal disease: a case-control study. J.Ren. Nutr. 2013, 23:340-347.
33. Badimon L., Martinez-Gonzalez J., Royo T., Lassila R., Badimon J.J. Asudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall-studies in a porcine model. Thromb. Haemost. 1999, 82:1736-1742.
34. Dzau V.J., Sacks F.M. Regulation of lipoprotein metabolism by adrenergic mechanisms. J.Cardiovasc. Pharmacol. 1987, 10(Suppl.9):S2-S6.
35. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Abedini S., Hansen J.F. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur. Heart J. 2004, 25:363-370.
36. Hijmering M.L., Stroes E.S., Olijhoek J., Hutten B.A., Blankestijn P.J., Rabelink T.J. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J.Am. Coll. Cardiol. 2002, 39:683-688.
37. Tesfamariam B., Weisbrod R.M., Cohen R.A. Cyclic GMP modulators on vascular adrenergic neurotransmission. J.Vasc. Res. 1992, 29:396-404.
38. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., Iwamoto Y., Thompson B., Carlson A.L., Heidt T., Majmudar M.D., Lasitschka F., Etzrodt M., Waterman P., Waring M.T., Chicoine A.T., van der Laan A.M., Niessen H.W., Piek J.J., Rubin B.B., Butany J., Stone J.R., Katus H.A., Murphy S.A., Morrow D.A., Sabatine M.S., Vinegoni C., Moskowitz M.A., Pittet M.J., Libby P., Lin C.P., Swirski F.K., Weissleder R., Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.